Sartorius Stedim Biotech and G-Con to combine products


To create an integrated production process platform for biopharmaceutical industry

Maik Jornitz

Maik Jornitz

Sign up for your free email newsletter

Laboratory equipment supplier Sartorius Stedim Biotech (SSB) has agreed a global collaboration with G-Con Manufacturing of the US in which the two companies will combine their products to create a totally integrated production process for the biopharmaceutical manufacturing industry.

The new product line will leverage College Station, Texas-based G-Con Manufacturing’s modular, mobile cleanroom ‘pods’ and Sartorius Stedim Biotech’s single-use and reusable product portfolio.

SSB has incorporated its products into unit operations for media/buffer preparation, seed fermentation, cell cultivation and harvesting, ultra-diafiltration, membrane chromatography and viral clearance for biopharmaceutical development and manufacturing.

Combining this technology with G-Con’s pod platform will provide a set of cost-effective, “plug and play” tools for next-generation manufacturing facilities, the firm said.

Maik Jornitz, SSB’s senior vice president of marketing for Bioprocess Solutions, said the combined product portfolio will fundamentally change the way biopharmaceutical manufacturing processes will be designed and configured.

‘Our Integrated Solutions unit will implement G-Con’s platform of modular cleanroom systems into their designs. In addition, our teams will benefit from G-Con’s engineering and design expertise. Our vision is to create standardised unit operations, implemented into the self-contained G-Con modules. These modules can be used as individual process units or joined to an entire process.’

Barry Holtz, president of G-Con Manufacturing, added: ‘Our common goal is to combine our complementary expertise to develop revolutionary solutions for the next generation of flexible, single-use manufacturing concepts. We couldn’t be more excited about having an agreement with a leader in single-use products like Sartorius Stedim Biotech.’

G-Con’s modular containment units will start to be rolled out globally in early 2012.

Jornitz said: ‘We do not want to delay the availability of the G-Con units and therefore decided to have our Integrated Solutions unit utilise the containment systems and G-Con’s engineering capabilities now. The global launch through our sales organisations will follow.’